Current Neuro-Oncology

Volume 27 Number 11
20 April 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 11, 20 April

Shi X, Sun X, Fan W, Dai X, Jiang M.
Impact of radiation response on survival in pediatric medulloblastoma with residual or disseminated disease.
Radiat Oncol. 2025 Apr 11;20(1):52. doi: 10.1186/s13014-025-02632-9. PMID: 40217253. Observational study. ˍ

Cao H, Huang Z, Qiu R, Xiao X, Li Z, Pillai JJ, Hua J, Huang G, Xu Y, Liang W, Wu Y.
Predicting progression of enhancing non-measurable disease in high-grade glioma by using dynamic contrast-enhanced MR imaging. Magn Reson Imaging. 2025 Apr 12:110394. doi: 10.1016/j.mri.2025.110394. PMID: 40222718. Observational study˰ ˍ

Li D, Chen Y, Wong TF, Yang Q, Guo C, Jiang X, Ke C, Zhang X, Zeng J, Lv Y, Wu S, Wang J, Sai K, Mou Y, Chen Z.
Management and survival trends for diffuse gliomas diagnosed at a single neurooncology center in China during 2000 to 2020.
Sci Rep. 2025 Apr 12;15(1):12574. doi: 10.1038/s41598-025-95693-5. PMID: 40221458. Observational study. ˍ

Diaz LS, Agrup M, Askild A, Embring A, Engellau J, Kristensen IF, Flejmer A, Fröjd C, Nilsson MP, Svärd AM, Walfridsson A, Blomstrand M.
Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05016-x. PMID: 40232619. Observational study. ˍ

Lesha E, Laird DG, Nichols CS, Miller LE, Orr T, Roach JT, Troy C, Vaughn B, Shimony N, Klimo P Jr.
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population.
J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05021-0. PMID: 40232620. Observational study. ˍ

Chung MW, Tzeng CC, Huang YC, Wei KC, Hsu PW, Chuang CC, Lin YJ, Chen KT, Lee CC.
Neutrophil-to-lymphocyte ratio dynamics: prognostic value and potential for surveilling glioblastoma recurrence.
BMC Cancer. 2025 Apr 16;25(1):709. doi: 10.1186/s12885-025-14118-8. PMID: 40241016. Observational study. ˍ

Li Y, Shen X, Zhang J, Xian X, Chen S, Zeng J, Hu W.
Adult diffuse IDH-wildtype lower-grade gliomas with PDGFRA gain/amplification should be upgraded as glioblastoma.
J Neuropathol Exp Neurol. 2025 Apr 16:nlaf039. doi: 10.1093/jnen/nlaf039. PMID: 40238212. Laboratory investigation˰ ˍ

Nakatogawa H, Fukai J, Kawaji H, Hayashi N, Yoshioka E, Kodama Y, Nakajo K, Uda T, Arakawa Y, Takada S, Kijima N, Ishibashi K, Okuda T, Sonoda Y, Ohue S, Arita H, Matsuda M, Fukami T, Tomita T, Inoue A, Achiha T, Kashiwagi H, Kanematsu D, Katsuma A, Sumida M, Shofuda T, Mano M, Kinoshita M, Mori K, Inenaga C, Kanemura Y.
Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort study.
Acta Neuropathol Commun. 2025 Apr 16;13(1):77. doi: 10.1186/s40478-025-01989-y. PMID: 40241149. Observational study. ˍ

Xu H, Jiang LH, Yu SN, Ren QL.
The Prognostic Value of the Systemic Immune-Inflammation Index in Glioblastoma Patients and the Establishment of a Nomogram.
Curr Med Sci. 2025 Apr 16. doi: 10.1007/s11596-025-00047-x. PMID: 40240723. Observational study˰ ˍ

Ballard CAP, Wang Y, Kruchko C, Barnholtz-Sloan JS, Li Y, Ostrom QT.
Characteristics of long-term glioblastoma survivors diagnosed from 2010 to 2016 in the United States.
Cancer Epidemiol. 2025 Apr 17;97:102810. doi: 10.1016/j.canep.2025.102810. PMID: 40250082. Observational study˰ ˍ

Campbell E, Todd L, Amato-Watkins A, O'Kane R, Sangra M, Canty M.
Prospective review of 30-day morbidity and mortality following surgery for brain tumours in children.
Childs Nerv Syst. 2025 Apr 17;41(1):162. doi: 10.1007/s00381-025-06817-1. PMID: 40246770. Observational study˰ ˍ

Fangusaro J, Onar-Thomas A, Young Poussaint T, Lensing S, Ligon AH, Lindeman N, Banerjee A, Kilburn LB, Lenzen A, Pillay-Smiley N, Pollack IF, Robison NJ, Partap S, Qaddoumi I, Landi D, Jones DTW, Stewart CF, Fouladi M, Dunkel IJ.
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4.
Neuro Oncol. 2025 Apr 17:noaf065. doi: 10.1093/neuonc/noaf065. PMID: 40241281. Interventional study˰ ˍ

Teffera Y, Tippin T, Bartkus A, de Castro FA, Faison SL, Morrison M, Mullin MJ, Naderer O.
A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants.
Clin Pharmacol Drug Dev. 2025 Apr 17. doi: 10.1002/cpdd.1541. PMID: 40243222. Interventional study˰ ˍ

Duffau H.
A series of 309 awake surgeries with transcortical approach for IDH-mutant low-grade glioma involving the insula: long-term onco-functional outcomes in 253 consecutive patients.
J Neurosurg. 2025 Apr 18:1-8. doi: 10.3171/2025.1.JNS242462. PMID: 40250045. Observational study. ˍ

Mu Y, Luo J, Xiong T, Zhang J, Lan J, Zhang J, Tan Y, Yang S.
Development and validation of nomogram model predicting overall survival and cancer specific survival in glioblastoma patients. Discov Oncol. 2025 Apr 18;16(1):562. doi: 10.1007/s12672-025-02331-7. PMID: 40249416. Observational study. ˍ

Pai EL, Matsumoto Y, Dou D, Nelluri S, Devi P, Priori S, Amankulor N, Alonso-Basanta M, Singh O, Abdullaev Z, Aldape K, Desai A, Mohan S, Nasrallah MP.
Letter to the Editor: Molecularly defined oligodendroglioma evolving to osseous metastases.
J Neuropathol Exp Neurol. 2025 Apr 18:nlaf038. doi: 10.1093/jnen/nlaf038. PMID: 40249402. Case report˰ ˍ

Xu P, Liu D, Hu H, Liu T, Liang C, Wen Z, Yuan K, Yin J, Orlandini LC, Lang J.
Magnetic resonance spectroscopy guided radiotherapy boost for patients with glioblastoma.
Sci Rep. 2025 Apr 18;15(1):13371. doi: 10.1038/s41598-025-87632-1. PMID: 40246915. Observational study. ˍ